Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · IEX Real-Time Price · USD
39.49
+2.12 (5.67%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Mirum Pharmaceuticals Stock Forecast
Stock Price Forecast
The 13 analysts with 12-month price forecasts for MIRM stock have an average target of 53.54, with a low estimate of 38 and a high estimate of 68. The average target predicts an increase of 35.58% from the current stock price of 39.49.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for MIRM stock from 13 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 4 | 5 | 5 |
| Buy | 6 | 7 | 7 | 7 | 8 | 8 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 9 | 10 | 11 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $66 | Strong Buy | Reiterates | $66 | +67.13% | Jul 8, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $66 | Strong Buy | Reiterates | $66 | +67.13% | Jun 28, 2024 |
| Stifel | Stifel | Strong Buy Maintains $48 → $66 | Strong Buy | Maintains | $48 → $66 | +67.13% | Jun 20, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $38 → $64 | Strong Buy | Maintains | $38 → $64 | +62.07% | Jun 18, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $31 → $39 | Buy | Maintains | $31 → $39 | -1.24% | Jun 18, 2024 |
Financial Forecast
Revenue This Year
322.31M
from 186.37M
Increased by 72.94%
Revenue Next Year
413.86M
from 322.31M
Increased by 28.40%
EPS This Year
-1.64
from -4.00
EPS Next Year
0.01
from -1.64
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 334.7M | 507.0M | 721.3M | 919.6M | 1.1B |
| Avg | 322.3M | 413.9M | 529.5M | 708.6M | 882.9M |
| Low | 306.5M | 373.4M | 411.6M | 510.6M | 641.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 79.6% | 57.3% | 74.3% | 73.7% | 59.1% |
| Avg | 72.9% | 28.4% | 27.9% | 33.8% | 24.6% |
| Low | 64.4% | 15.8% | -0.5% | -3.6% | -9.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.29 | 2.32 | 6.13 | 7.37 | 10.29 |
| Avg | -1.64 | 0.01 | 1.79 | 3.53 | 5.63 |
| Low | -2.02 | -1.93 | -1.41 | -0.09 | 1.21 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | 40,964.0% | 312.6% | 191.1% |
| Avg | - | - | 11,863.8% | 97.8% | 59.2% |
| Low | - | - | - | - | -65.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.